Juvenile exposure to ketamine causes delayed emergence of EEG abnormalities during adulthood in mice

Drug and Alcohol Dependence

Volumn 134, Issue 1, 2014, Pages 123-127

  Featherstone, R E ^a   Nagy, L R ^a   Hahn, C G ^a   Siegel, S J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Drug abuse; Gamma; NMDA; Oscillations; Schizophrenia; Theta

Indexed keywords

KETAMINE;

ADULT; ADULTHOOD; AGE DISTRIBUTION; ANIMAL EXPERIMENT; ARTICLE; DRUG ABUSE; EEG ABNORMALITY; ELECTROENCEPHALOGRAM; EVENT RELATED POTENTIAL; GAMMA RHYTHM; JUVENILE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THETA RHYTHM;

MUS;

DRUG-ABUSE; GAMMA; NMDA; OSCILLATIONS; SCHIZOPHRENIA; THETA;

ACOUSTIC STIMULATION; AGE FACTORS; ANIMALS; ELECTRODES, IMPLANTED; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; KETAMINE; MALE; MICE; MICE, INBRED C3H; REACTION TIME;

EID: 84890154130     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.09.017     Document Type: Article

References (51)

1. Adler L.E., Olincy A., Waldo M., Harris J.G., Griffith J., Stevens K., Flach K., Nagamoto H., Bickford P., Leonard S., Freedman R. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr. Bull. 1998, 24:189-202.
2. Amann L.C., Halene T.B., Ehrlichman R.S., Luminais S.N., Ma N., Abel T., Siegel S.J. Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials. Neurobiol. Dis. 2009, 35:311-317.
3. Becker A., Grecksch G. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia, test of predictive validity. Prog. Neuropsychopharmacol. Biol. Psychiatry 2004, 28:1267-1277.
4. Becker A., Peters B., Schroeder H., Mann T., Huether G., Grecksch G. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2003, 27:687-700.
5. Behrens M.M., Sejnowski T.J. Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?. Neuropharmacology 2009, 57:193-200.
6. Carlen M., Meletis K., Siegle J.H., Cardin J.A., Futai K., Vierling-Claassen D., Ruhlmann C., Jones S.R., Deisseroth K., Sheng M., Moore C.I., Tsai L.H. A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Mol. Psychiatry 2011, 17:537-548.
7. Chatterjee M., Verma R., Ganguly S., Palit G. Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice. Neuropharmacology 2012, 63:1161-1171.
8. Connolly P.M., Maxwell C., Liang Y., Kahn J.B., Kanes S.J., Abel T., Gur R.E., Turetsky B.I., Siegel S.J. The effects of ketamine vary among inbred mouse strains and mimic schizophrenia for the P80, but not P20 or N40 auditory ERP components. Neurochem. Res. 2004, 29:1179-1188.
9. Delorme A., Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J. Neurosci. Methods 2004, 134:9-21.
10. Duzel E., Penny W.D., Burgess N. Brain oscillations and memory. Curr. Opin. Neurobiol. 2010, 20:143-149.
11. Ehrlichman R.S., Maxwell C.R., Majumdar S., Siegel S.J. Deviance-elicited changes in event-related potentials are attenuated by ketamine in mice. J. Cogn. Neurosci. 2008, 20:1403-1414.
12. Ehrlichman R.S., Gandal M.J., Maxwell C.R., Lazarewicz M.T., Finkel L.H., Contreras D., Turetsky B.I., Siegel S.J. N-methyl-D-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia. Neuroscience 2009, 158:705-712.
13. Featherstone R.E., Liang Y., Saunders J.A., Tatard-Leitman V.M., Ehrlichman R.S., Siegel S.J. Subchronic ketamine treatment leads to permanent changes in EEG, cognition and the astrocytic glutamate transporter EAAT2 in mice. Neurobiol. Dis. 2012, 47:338-346.
14. Fredriksson A., Ponten E., Gordh T., Eriksson P. Neonatal exposure to a combination of N-methyl-D-aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits. Anesthesiology 2007, 107:427-436.
15. Gandal M.J., Sisti J., Klook K., Ortinski P.I., Leitman V., Liang Y., Thieu T., Anderson R., Pierce R.C., Jonak G., Gur R.E., Carlson G., Siegel S.J. GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction. Transl. Psychiatry 2012, 2:e142.
16. Gonzalez-Burgos G., Hashimoto T., Lewis D.A. Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr. Psychiatry Rep. 2011, 12:335-344.
17. Huang L., Liu Y., Jin W., Ji X., Dong Z. Ketamine potentiates hippocampal neurodegeneration and persistent learning and memory impairment through the PKCgamma-ERK signaling pathway in the developing brain. Brain Res. 2012, 1476:164-171.
18. Huppe-Gourgues F., O'Donnell P. D(1)-NMDA receptor interactions in the rat nucleus accumbens change during adolescence. Synapse 2012, 66:584-591.
19. Johannesen J.K., Bodkins M., O'Donnell B.F., Shekhar A., Hetrick W.P. Perceptual anomalies in schizophrenia co-occur with selective impairments in the gamma frequency component of midlatency auditory ERPs. J. Abnorm. Psychol. 2008, 117:106-118.
20. Lazarewicz M.T., Ehrlichman R.S., Maxwell C.R., Gandal M.J., Finkel L.H., Siegel S.J. Ketamine modulates theta and gamma oscillations. J. Cogn. Neurosci. 2010, 22:1452-1464.
21. Lega B.C., Jacobs J., Kahana M. Human hippocampal theta oscillations and the formation of episodic memories. Hippocampus 2012, 22:748-761.
22. Lewis D.A., Gonzalez-Burgos G. Pathophysiologically based treatment interventions in schizophrenia. Nat. Med. 2006, 12:1016-1022.
23. Lewis D.A., Volk D.W., Hashimoto T. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology (Berl.) 2004, 174:143-150.
24. Lewis D.A., Hashimoto T., Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat. Rev. 2005, 6:312-324.
25. Liao Y., Tang J., Ma M., Wu Z., Yang M., Wang X., Liu T., Chen X., Fletcher P.C., Hao W. Frontal white matter abnormalities following chronic ketamine use: a diffusion tensor imaging study. Brain 2010, 133:2115-2122.
26. Liao Y., Tang J., Corlett P.R., Wang X., Yang M., Chen H., Liu T., Chen X., Hao W., Fletcher P.C. Reduced dorsal prefrontal gray matter after chronic ketamine use. Biol. Psychiatry 2011, 69:42-48.
27. Majewski-Tiedeken C.R., Rabin C.R., Siegel S.J. Ketamine exposure in adult mice leads to increased cell death in C3H, DBA2 and FVB inbred mouse strains. Drug Alcohol Depend. 2008, 92:217-227.
28. Maxwell C.R., Ehrlichman R.S., Liang Y., Trief D., Kanes S.J., Karp J., Siegel S.J. Ketamine produces lasting disruptions in encoding of sensory stimuli. J. Pharmacol. Exp. Ther. 2006, 316:315-324.
29. Morgan C.J., Muetzelfeldt L., Curran H.V. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. Addiction 2010, 105:121-133.
30. Narendran R., Frankle W.G., Keefe R., Gil R., Martinez D., Slifstein M., Kegeles L.S., Talbot P.S., Huang Y., Hwang D.R., Khenissi L., Cooper T.B., Laruelle M., Abi-Dargham A. Altered prefrontal dopaminergic function in chronic recreational ketamine users. Am. J. Psychiatry 2005, 162:2352-2359.
31. Nikiforuk A., Popik P. Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in rats. Psychopharmacology (Berl.) 2012, 220:65-74.
32. Paule M.G., Li M., Allen R.R., Liu F., Zou X., Hotchkiss C., Hanig J.P., Patterson T.A., Slikker W., Wang C. Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys. Neurotoxicol. Teratol. 2011, 33:220-230.
33. Pope H.G., Gruber A.J., Hudson J.I., Cohane G., Huestis M.A., Yurgelun-Todd D. Early-onset cannabis use and cognitive deficits: what is the nature of the association?. Drug Alcohol Depend. 2003, 69:303-310.
34. Roach B.J., Mathalon D.H. Event-related EEG time-frequency analysis: an overview of measures and an analysis of early gamma band phase locking in schizophrenia. Schizophr. Bull. 2008, 34:907-926.
35. Rojas D.C., Maharajh K., Teale P.D., Kleman M.R., Benkers T.L., Carlson J.P., Reite M.L. Development of the 40Hz steady state auditory evoked magnetic field from ages 5 to 52. Clin. Neurophysiol. 2006, 117:110-117.
36. Rushforth S.L., Steckler T., Shoaib M. Nicotine improves working memory span capacity in rats following sub-chronic ketamine exposure. Neuropsychopharmacology 2011, 36:2774-2781.
37. Scallet A.C., Schmued L.C., Slikker W., Grunberg N., Faustino P.J., Davis H., Lester D., Pine P.S., Sistare F., Hanig J.P. Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicol. Sci. 2004, 81:364-370.
38. Siegel C., Waldo M., Mizner G., Adler L.E., Freedman R. Deficits in sensory gating in schizophrenic patients and their relatives, evidence obtained with auditory evoked responses. Arch. Gen. Psychiatry 1984, 41:607-612.
39. Siegel S.J., Connolly P., Liang Y., Lenox R.H., Gur R.E., Bilker W.B., Kanes S.J., Turetsky B.I. Effects of strain, novelty, and NMDA blockade on auditory-evoked potentials in mice. Neuropsychopharmacology 2003, 28:675-682.
40. Slikker W., Zou X., Hotchkiss C.E., Divine R.L., Sadovova N., Twaddle N.C., Doerge D.R., Scallet A.C., Patterson T.A., Hanig J.P., Paule M.G., Wang C. Ketamine-induced neuronal cell death in the perinatal rhesus monkey. Toxicol. Sci. 2007, 98:145-158.
41. Tesche C.D., Karhu J. Theta oscillations index human hippocampal activation during a working memory task. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:919-924.
42. Tseng K.Y., O'Donnell P. Post-pubertal emergence of prefrontal cortical up states induced by D1-NMDA co-activation. Cereb. Cortex 2005, 15:49-57.
43. Uhlhaas P.J., Singer W. Abnormal neural oscillations and synchrony in schizophrenia. Nat. Rev. Neurosci. 2010, 11:100-113.
44. Uhlhaas P.J., Singer W. The development of neural synchrony and large-scale cortical networks during adolescence: relevance for the pathophysiology of schizophrenia and neurodevelopmental hypothesis. Schizophr. Bull. 2011, 37:514-523.
45. Uhlhaas P.J., Roux F., Singer W., Haenschel C., Sireteanu R., Rodriguez E. The development of neural synchrony reflects late maturation and restructuring of functional networks in humans. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9866-9871.
46. Wang H.X., Gao W.J. Cell type-specific development of NMDA receptors in the interneurons of rat prefrontal cortex. Neuropsychopharmacology 2009, 34:2028-2040.
47. Werkle-Bergner M., Shing Y.L., Muller V., Li S.C., Lindenberger U. EEG gamma-band synchronization in visual coding from childhood to old age: evidence from evoked power and inter-trial phase locking. Clin. Neurophysiol. 2009, 120:1291-1302.
48. Wiley J.L., Evans R.L., Grainger D.B., Nicholson K.L. Age-dependent differences in sensitivity and sensitization to cannabinoids and 'club drugs' in male adolescent and adult rats. Addict. Biol. 2008, 13:277-286.
49. Young C., Jevtovic-Todorovic V., Qin Y.Q., Tenkova T., Wang H., Labruyere J., Olney J.W. Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain. Br. J. Pharmacol. 2005, 146:189-197.
50. Yu H., Li Q., Wang D., Shi L., Lu G., Sun L., Wang L., Zhu W., Mak Y.T., Wong N., Wang Y., Pan F., Yew D.T. Mapping the central effects of chronic ketamine administration in an adolescent primate model by functional magnetic resonance imaging (fMRI). Neurotoxicology 2012, 33:70-77.
51. Zou X., Patterson T.A., Sadovova N., Twaddle N.C., Doerge D.R., Zhang X., Fu X., Hanig J.P., Paule M.G., Slikker W., Wang C. Potential neurotoxicity of ketamine in the developing rat brain. Toxicol. Sci. 2009, 108:149-158.